SCHEMBL94274

SCHEMBL94274

O=S(=O)(O)c1cc(S(=O)(=O)O)c2nc[nH]c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNP P00491 1/20 0.38
C1S P09871 1/20 0.37
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
LMNA P02545 2/20 0.35
POLB P06746 1/20 0.35
ALDH1A1 P00352 2/20 0.33
PRNP P04156 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PARP1 P09874 1/20 0.33
LCK P06239 1/20 0.32
FYN P06241 1/20 0.32
HTR6 P50406 1/20 0.32
CCKBR P32239 1/20 0.32
ING2 Q9H160 1/20 0.32
HDAC6 Q9UBN7 1/20 0.31
FEN1 P39748 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29687182 1.00 PNP (0.38) PNPC1SMEN1KMT2ALMNA
SCHEMBL27613262 0.98 PNP (0.37) PNPC1SMEN1KMT2ALMNA
SCHEMBL28122236 0.98 PNP (0.37) PNPC1SMEN1KMT2ALMNA
SCHEMBL28539517 0.87 C1S (0.37) PNPC1SMEN1KMT2AALDH1A1
SCHEMBL29771162 0.87 C1S (0.37) PNPC1SMEN1KMT2AALDH1A1
SCHEMBL28233407 0.74 PARP1 (0.51) MEN1KMT2ALMNAPOLBPARP1
SCHEMBL338619 0.72 CYP2C19 (0.36) ALDH1A1PARP1LCKFYNING2
SCHEMBL11222589 0.72 PARP1 (0.50) MEN1KMT2ALMNAPOLBPARP1
SCHEMBL571364 0.71 PRKCI (0.52) KMT2APOLBALDH1A1MAPTHPGD
SCHEMBL29724218 0.71 PRKCI (0.52) KMT2APOLBALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 611 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3389621-B1 EMULSIONS CONTAINIG UV-SCREENS AND CARNOSINES SYMRISE AG (DE) 2022-10-19 EP claimed
CN-102448429-B Benzylidene malonates 巴斯夫欧洲公司 2018-03-06 CN claimed
US-9656103-B2 Light protecting-effective cosmetic or dermatological preparations BASF SE (DE) 2017-05-23 US claimed
EP-3052202-A1 SKIN TANNING EXTRACT DSM IP Assets B.V. (NL) 2016-08-10 EP claimed
WO-2015049366-A1 SKIN TANNING EXTRACT DSM IP ASSETS B.V. (NL) 2015-04-09 WO claimed
WO-2012116990-A2 NOVEL USE DSM IP ASSETS B.V. (NL) 2012-09-07 WO claimed
EP-2410974-A2 SUNSCREEN COMPOSITION COMPRISING HYDROXYAPATITE AS PHYSICAL SOLAR FILTER Kalichem Italia S.r.l. (IT) 2012-02-01 EP claimed
WO-2010109400-A2 SUNSCREEN PRODUCT COMPRISING HYDROXYAPATITE AS PHYSICAL FILTER KALICHEM ITALIA S.R.L. (IT) 2010-09-30 WO claimed
EP-1768644-B1 LIGHT PROTECTING-EFFECTIVE COSMETIC OR DERMATOLOGICAL PREPARATIONS CIBA HOLDING INC (CH) 2009-02-18 EP claimed
EP-1768644-A1 LIGHT PROTECTING-EFFECTIVE COSMETIC OR DERMATOLOGICAL PREPARATIONS Ciba SC Holding AG (CH) 2007-04-04 EP claimed
EP-1703892-A2 UV LIGHT-STABLE SEMI-SOLID TRANSDERMAL SYSTEMS COMPRISING A PHOTOSENSITIVE ACTIVE AGENT AND AN UV-ABSORBING COMPONENT Schering AG (DE) 2006-09-27 EP claimed
WO-2006008252-A1 LIGHT PROTECTING-EFFECTIVE COSMETIC OR DERMATOLOGICAL PREPARATIONS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-01-26 WO claimed
WO-2005055975-A2 UV-STABLE SEMI-SOLID TRANSDERMAL SYSTEMS COMPRISING A PHOTOSENSITIVE ACTIVE INGREDIENT AND A UV ABSORBER SCHERING AG (DE) 2005-06-23 WO claimed
EP-1407757-A1 Preparation of micronised UV absorbers Ciba SC Holding AG (CH) 2004-04-14 EP claimed
EP-3442354-B1 FORMULATION AND PRODUCTION OF SPINACH EXTRACT WITH BETA ECDYSON DR GOETZ GMBH (DE) 2026-05-20 EP disclosed
EP-3969013-B1 SKIN TREATMENT METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY OF ACTIVE AGENTS TOPIX PHARMACEUTICALS INC (US) 2026-01-07 EP disclosed
US-20250302705-A1 TOPICAL VITAMIN C COMPOSITION TOPIX PHARMACEUTICALS INC (US) 2025-10-02 US disclosed
US-4517254-A ALKALI METAL HYDROXIDE, AMINOALKYLPOLYACID COMPOUNT SCHERING AKTIENGESELLSCHAFT (DE) 1985-05-14 US disclosed
EP-0139090-A1 Process for the pre-treatment of polyimides SCHERING AKTIENGESELLSCHAFT (DE) 1985-05-02 EP disclosed
US-4248632-A ACTIVATION OF A POLYMER SURFACE WITH A PALLADIUM COMPLEX SALT SCHERING AKTIENGESELLSCHAFT (DE) 1981-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250302705-A1 TOPICAL VITAMIN C COMPOSITION PROC, TTPA, SOD3 PNP 3207/4885C1S 105/4885MEN1 4749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.